In several controlled studies, epoetins have not been shown to improve overall survival or decrease the risk of tumour progression in patients with anaemia associated with cancer.
I adskillige kontrollerede studier er det ikke påvist at Epoetin kan forbedre den overordnede overlevelse eller mindske risikoen for tumorprogression hos patienter med cancerrelateret anæmi.